Supernus Pharmaceuticals, Inc. - SUPN

SEC FilingsOur SUPN Tweets

About Gravity Analytica

Recent News

  • 06.04.2025 - 2025 Jefferies Global Healthcare Conference
  • 06.04.2025 - 2025 Jefferies Global Healthcare Conference
  • 05.29.2025 - Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals
  • 05.29.2025 - Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals
  • 05.29.2025 - Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals
  • 05.28.2025 - Supernus Announces Paragraph IV ANDA Filings for Qelbree®
  • 05.28.2025 - Supernus Announces Paragraph IV ANDA Filings for Qelbree®
  • 05.28.2025 - Supernus to Participate in the 2025 Jefferies Global Healthcare Conference
  • 05.28.2025 - Supernus to Participate in the 2025 Jefferies Global Healthcare Conference
  • 05.28.2025 - Supernus to Participate in the 2025 Jefferies Global Healthcare Conference

Recent Filings

  • 05.28.2025 - 8-K Current report
  • 05.28.2025 - EX-99.1 EX-99.1
  • 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors